Altium Capital Management LP X4 Pharmaceuticals, Inc Transaction History

Altium Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.9 - $5.6 $1.53 Million - $4.51 Million	-804,598 Closed	0 $0
Q3 2021 Nov 17, 2021	BUY	$4.53 - $6.45 $8,607 - $12,255	1,900 Added 0.24%	804,598 $4.26 Million
Q3 2021 Nov 15, 2021	BUY	$4.53 - $6.45 $3.64 Million - $5.18 Million	802,698 New	802,698 $4.15 Million

103

99.9M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $41.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.